Therascreen® KRAS RGQ PCR Kit

Clinical trial NCT05347745 · COMPLETED

Trial details

NCT number: NCT05347745
Sponsor: QIAGEN Gaithersburg, Inc
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Colo-rectal Cancer

Start date: 2022-01-07
Primary completion: 2023-03-30
Enrollment: 219

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.